Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2.59M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
1.08M
-
Shares change
-
+123K
-
Total reported value, excl. options
-
$3.01M
-
Value change
-
+$253K
-
Number of buys
-
6
-
Number of sells
-
-7
-
Price
-
$2.80
Significant Holders of Aptose Biosciences Inc. - Common Shares (APTO) as of Q3 2023
26 filings reported holding APTO - Aptose Biosciences Inc. - Common Shares as of Q3 2023.
Aptose Biosciences Inc. - Common Shares (APTO) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.08M shares
of 2.59M outstanding shares and own 41.54% of the company stock.
Largest 10 shareholders include DRW Securities, LLC (593K shares), Sigma Planning Corp (146K shares), Nantahala Capital Management, LLC (136K shares), CARLSON CAPITAL L P (107K shares), MORGAN STANLEY (46.9K shares), CITADEL ADVISORS LLC (17.4K shares), Cetera Advisors LLC (15K shares), TORONTO DOMINION BANK (4.6K shares), US BANCORP \DE\ (2.02K shares), and WELLS FARGO & COMPANY/MN (1.71K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.